FAS and obesity due to melanocortin 4 receptor deficiency: Yan reported that the inhibitors of FAS reduced lipid accumulation and increased Mal-CoA, Ac-CoA, and NADPH release, which reduced fat accumulation, inhibited adipocyte differentiation, and expedited energy consumption to treat obesity [38].